Can I read Mifepristone REMS Program Overview on EtoBox?

Mifepristone REMS Program Overview by Bud Shaver is a document available to read on EtoBox.

What is Mifepristone REMS Program Overview about?

Initial REMS approval was on November 2018 for Mifepristone Tablets, 200 mg, a progestin antagonist. The goal of the REMS is to mitigate serious risks by requiring that healthcare providers be certified to prescribe mifepristone and confirm patients understand the risks of treatment. Certified prescribers must review the prescribing information, sign a agreement form, counsel patients and obtain their informed consent. Mifepristone sponsors must ensure it is only distributed to certified healthcare offi

Author

Bud Shaver

Language

EN